| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Negotiation > Negotiations Between Artist and Gallery-Contracts Must Be Clear, Flattery Gets Ya Nowhere Pt. 3 |
|
Main Subject - Negotiations Between Artist and Gallery-Contracts Must Be Clear, Flattery Gets Ya Nowhere Pt. 3
Part Three: Galleries need to create a close relationship with their artists. According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product They need to nurture the fledglings, and hype established artists. They need to create a f ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in mily in a sense. They need to know that if the gallery fails they will have their work ret lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. rned to them safely. Without that I am personally not comfortable being in a gallery no ma here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ter where it is. An artist should not undervalue themselves and ship out their work just b d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cause they are flattered for being asked. Likewise galleries need to respect the talent a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nd energy that goes into a piece of art by attending to the details that make the relations easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ip work and therefore become successful. That was a real leaning experience for me as nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ou might imagine. I have had other nightmares also, so I have had to put on a business hat and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ s well as being an artist. Bad experiences are the reason I am extra cautious as to who an ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi where I ship my work to. Normally I have a pretty strong bond with a gallery owner before ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a I ship. A few questions to ask a gallery: Who pays the shipping costs? T dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod and From. Is there insurance, if so with who? and for how much? Is there a trial cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin period? Who, what, where is the gallery owner? Will the artist be notified if the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen r work is temporarily put in storage? Do they rent the work out? If so what is the ar t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ist's cut? What % of a sale is due to the artist? This list goes on of course. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Think it through before you leave your work in any gallery. Gallery owners know how thing y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products should work, get your contracts complete and well thought out 'before' you approach an a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tist. A good book to get is the latest Artist's and Graphic Designer's Market. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip It is full of info both for gallery owners and artists. --------------------------- tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Strategically Starting a New Job Meeting Minutes - Why You Need Them And How To Use An Outsourced Minute Taker How Movies Can Help You Handle the Stress of Business Traveling
|